Abbott, AbbVie Pay $25M Over Off-Label Promos, Kickbacks
By Jeff Overley · October 26, 2018, 6:25 PM EDT
Abbott Laboratories and AbbVie Inc. will fork over $25 million to end a whistleblower's False Claims Act case alleging off-label promotion of triglyceride drug TriCor and unlawful kickbacks in the form...
To view the full article, register now.